A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
Clinical trial NCT03070301 · COMPLETED
Trial details
- NCT number
- NCT03070301
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-27
- Primary completion
- 2024-01-31
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.